Poor knowledge about this potential threat hampers human health
Environment and heredity are smaller players than researchers previously believed
Biotech companies are on the prowl for newer, better antivenoms
The number of positions hit a record high this year, even as the number of non-U.S. citizens who applied declined
It remains to be seen whether the treatment, which was effective in a large clinical trial, will live up to its promise
The discovery may help doctors identify elusive infected cells in the body
In a rethink of personalized medicine, researchers turn to banks of donor-derived stem cells
Testing every newborn for a raft of known genetic risks is technologically feasible. Some worry the results could do more harm than good
The national plan aims to change the way drugs are prescribed
Doing large studies of marijuana's potential as medicine means getting it removed from an official federal list of substances with no official medical use—which requires more proof of its potential as medicine.
Red blood cells retain a memory of high-altitude exposure, allowing for faster acclimation next time. But that memory fades within four months. Christopher Intagliata reports.
No one wants active viral outbreaks—but researchers need them to make sure vaccinations work
Some advanced cancers can now be successfully treated by synthetic immune cells that are more powerful and longer-lasting than any found in the body
Functional intestine becomes the latest lab-grown organ
10 years of FDA data paint a grim picture of teething product complaints
Merck halts a late-stage trial of verubecestat, which targeted an enzyme involved in brain plaque formation
Recently we talked about the two-way connection between the brain and the small and large intestines (aka the gut). This week, Savvy Psychologist Dr. Ellen Hendriksen continues our journey through the gut by investigating the link between heartburn drugs and dementia
Doctors and patients are grappling with the unsettling finding that chronic use of popular heartburn medicines may be riskier than was thought
Suddenly in demand, naloxone injector goes from $690 to $4,500
Trevor Mundel, president of global health at the Gates Foundation, talks to Scientific American editor-in-chief Mariette DiChristina about the Coalition for Epidemic Preparedness Innovations (CEPI) and the efforts to create vaccine platforms for rapid responses to epidemics.